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ABSTRACT 
 
Introduction: Few studies on instruments for staging FTD have been conducted. 
Objective: To analyze the factor structure, internal consistency, reliability and 
convergent validity of the Brazilian version of the Frontotemporal Dementia Rating 
Scale (FTD-FRS). Methods: 97 individuals aged ≥ 40 years with > 2 years´ education 
took part in the study, 31 patients diagnosed with behavioral variant FTD (bvFTD), 8 
patients with primary progressive aphasia (PPA), 28 with AD, 8 with mild cognitive 
impairment (MCI), and a control group of 22 healthy subjects. The FTD-FRS was 
completed by family members or caregivers and Neurologists completed the 8-item 
CDR-FTLD scale (six original domains plus Language and Behavior). The AD and 
FTD patients had equivalent disease severity level. Results: The internal consistency of 
the FTD-FRS, estimated by Cronbach´s alpha, was 0.975 while test-retest reliability 
was 0.977. Scree plot and exploratory factor (Varimax rotation) analyses revealed the 
existence of four factors, with eigenvalues >1, which together explained 77.13% of the 
total variance with values of 1.28 to 17.52. The domains of the Brazilian version of the 
FTD-FRS scale correlated with the domains of the CDR-FTLD. Conclusions: The 
present study is the first to document the factorial structure of the FTD-FRS and its 
convergent validity with the CDR-FTLD. These tools are key to determine dementia 
severity in FTD. The Brazilian FTD-FRS demonstrated adequate psychometric 
properties for use in Brazil. This instrument may contribute to disease staging in FTD 
and may help to document intervention-related changes. 
 
Key words: staging, dementia progression, frontotemporal dementia, behavioral variant 
frontotemporal dementia, primary progressive aphasia. 
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Introduction 
Staging of dementia allows better management of the clinical condition and can 
help reduce caregiver dependency and burden1,2. Dementia severity assessment scales 
can be more suitable for monitoring the course of symptoms of neurodegenerative 
diseases than brief cognitive assessment measures, such as the MMSE, or 
neuropsychological assessment3. However, scales for staging dementia were developed 
based on symptoms of Alzheimer´s Disease (AD) and are potentially less sensitive to 
the progression observed in other dementias 4.    
Currently, the most widely used dementia staging scale worldwide is the Clinical 
Dementia Rating (CDR) 5,6. This is a semi-structured interview performed with both 
patient and their caregiver that collects information on six functional domains (memory, 
orientation, judgment and problem solving, community affairs, home and hobbies, and 
personal care).  Each domain is rated as 0, 0.5, 1, 2 and 3, where higher scores indicate 
worse functioning in the domain. All the domains taken together yield a global CDR 
score also ranging from 0 to 35, with 0 indicating no impairment, 0.5 questionable 
impairment, 1.0 mild impairment, 2.0 moderate impairment and 3.0 severe impairment. 
More recently, a CDR version was devised that includes two additional domains 
which are often impaired in frontotemporal dementia (FTD), namely, language and 
behavior, forming the Clinical Dementia Rating Scale for FTLD (CDR-FTLD)7. These 
new domains provide information on the specific symptoms of the variants of FTD, i.e. 
the primary progressive aphasias (PPA) and behavioral variant frontotemporal dementia 
(bvFTD), which can significantly impact severity assessment of these conditions8. In 
other words, individuals with FTD may be defined as having questionable or mild 
impairment on the CDR in the absence of assessment of these additional domains.      
Given the need to develop specific instruments for staging typical symptoms of 
FTD variants, Mioshi et al. 4  developed the Frontotemporal Dementia Rating Scale 
(FTD-FRS). The FTD-FRS was structured based on the questions from the Disability 
Assessment For Dementia (DAD) functional scale9 and the Cambridge Behavioral 
Inventory (CBI)10,11, producing a 75-item questionnaire covering behavioral disorders 
and functional disability. The new instrument was applied in a sample of 77 FTD 
patients (behavioral variant=29; semantic variant=28; non-fluent variant=20), matched 
for age and length of symptoms. After analysis of the psychometric characteristics and 
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construct validity for staging the dementia condition, the scale was shortened to 30 
items. 
In the study by Mioshi et al. 4, six stages of severity were identified by the scale 
(very mild, mild, moderate, severe, very severe and advanced/profound). The FTD-FRS 
was capable of detecting functional deterioration in the three clinical variants of FTD 
over 12 months. The decline in FTD-FRS over this period was found to differ across the 
FTD subtypes, where bvFTD progressed the most rapidly. Lastly, the scale was useful 
for assessing progression given that length of behavioral symptoms and global cognitive 
assessments, alone, do not reflect severity in FTD. The internal consistency with 
Cronbach´s alpha was 0.93 and stability on the test-retest was 0.994, suggesting good 
psychometric characteristics.  
Turró-Garriga et al.12 carried out the translation and adaptation of the FTD-FRS 
into Spanish. The authors recruited 82 patients, comprising 60 with bvFTD and 22 with 
AD. The Spanish-language version of the FTD-FRS displayed good internal consistency 
(α= 0.897) and strong correlation with the MMSE, DAD and CDR. The severity of 
dementia was rated as more severe by the FTD-FRS than by the CDR. 
 The FTD-FRS has been translated and adapted into Portuguese for use in Brazil. 
After back-translation, pilot application and assessment by specialist judges, the final 
version of the scale was produced13. Application of this version of the FTD-FRS in a 
pilot study suggested the scale is adequate for use in Brazil. However, no studies 
assessing the validity of the Brazilian version of the scale have been conducted. 
Therefore, the objective of the present study was to examine the factor structure, 
internal consistency, temporal stability and convergent validity with the MMSE and 
CDR-FTLD. 
 
Methods 
This is a cross-sectional analysis based on the initial dataset of a clinical study 
including healthy controls (HC), bvFTD, AD, PPA and mild cognitive impairment 
(MCI) patients. 
 
Participants 
Databases from university-based neurology outpatient services were consulted 
and patients and their caregivers were invited to take part in the study, at the following 
institutions: Cognitive and Behavioral Neurology Group (GNCC-SP) and Program for 
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the Elderly (PROTER) at the University of São Paulo; Cognitive and Behavioral 
Neurology Group (GNCC-MG) at the Federal University of Minas Gerais and the 
Department of Neurology at the State University of Campinas (UNICAMP). HC 
participants were recruited from an Open University for the Third Age.  
The diagnosis of dementia patient was performed by neurologists, geriatricians 
and psychiatrists, based on clinical and cognitive assessments along with laboratory and 
neuroimaging exams. Dementia was diagnosed based on the criteria from the 
Diagnostic and Statistical Manual 5th Edition (DSM-V)14. International diagnostic 
criteria were employed for diagnosing probable bvFTD1. The National Institute on 
Aging- Alzheimer's Association- NIA/AA criteria were used for AD diagnosis16, 17. 
Patients at mild and moderate stages (CDR 0.5-2.0) of bvFTD1 and AD5,6 were selected. 
The criteria recommended by Gorno-Tempini et al. were used for diagnosing semantic 
and non-fluent variants of FTD18. MCI (amnestic and non-amnestic) were diagnosed 
based on the criteria of Albert et al. 19. 
Inclusion criteria for patients were age >40 years, education >2 years and 
presence of an informant who was involved in the daily routine of the patient (formal or 
informal caregiver, spending at least 8 hours/day with the patient). Individuals 
presenting with visual, auditory or motor deficits preventing them from understanding 
instructions or performing cognitive tasks; individuals with other uncontrolled clinical 
diseases (such as hypertension and diabetes); serious and debilitating psychiatric 
disorders such as major depression, schizophrenia, bipolar disorder; clinical evidence or 
neuroimaging exam findings suggestive of vascular problems; dementias or etiologies 
other than FTD or AD, were excluded. 
For the control group, participants that were illiterate, scored > 5 on the Geriatric 
Depression Scale (GDS)20 or whose performance on the MMSE was below the cut-off 
point for dementia21 were excluded. The following cut-off points were adapted for 
educational level: 1-4 years´ education, 22 points; 5-8 years, 24 points; > 8 years, 26 
points. These cut-off scores were adapted from Brucki et al. 21 based on the mean for 
each educational band minus one standard deviation. Additionally, subjects exhibiting 
functional changes suggestive of dementia on the Functional Activities Questionnaire 
(FAQ>2)22,23 were also excluded.  
Caregivers included in the study were mostly women, with mean age of 54.1 
(SD ± 15.4) and mean educational level of 12.9 (SD ± 3.8). 
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Instruments 
Patient protocol 
A questionnaire collecting sociodemographic and clinical data including age, 
income, years of education, marital status, general health status, presence of other 
clinical disease and use of medications was applied. This block of the protocol was 
applied to controls and caregivers of dementia patients.  
 
Cognitive assessment 
The Addenbrooke´s Cognitive Examination-Revised ACE-R24,25 was used and 
provided scores for the MMSE. The maximum score is 100 points, distributed among 
the domains: attention and orientation (18), memory (35), verbal fluency (14), language 
(28) and visual-spatial ability (5). The cut-off point for dementia on the battery is 78 
points (Brazilian version)25. 
 
Family member/companion protocol 
Functional Assessment 
  The FAQ is based on an indirect assessment of patient functioning. The scale 
comprises ten items that investigate the degree of independence for performing 
activities of daily living. The minimum score is zero and maximum 30 points where 
higher scores indicate greater degree of dependency of the patient22,23.   
Dementia staging scales 
The CDR-FTLD version adapted by Knopman et al.1 was used. This version of 
the scale includes the assessment of the domains memory, orientation, judgment and 
problem solving, community affairs, home and hobbies, and personal care from the 
original, plus the domains of language and behavior. Part of the assessment is 
performed with the patient while a complementary semi-structured interview is 
conducted with their companion. Based on the data collected, the clinician rates each 
domain with scores of  0, 0.5, 1, 2 and 3, and finally provides a global rating of the 
patient´s cognitive status using this same rating scale for total score. The CDR-FTLD 
sum of boxes scores was also employed in this study.   
The FTD-FRS assesses the domains: Behavior, Outing and Shopping, 
Household chores (use  of Telephone, Finances, Medications, Meal Preparation), Self-
care and Mobility. Response options for each question are: All the time=0; 
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Sometimes=0 and Never=1. The “Never” answers are tallied and divided by the number 
of questions (ranging from 0-30) answered by the interviewee, multiplied by 100 
(number of “Never” responses/number of questions answered x 100) to give a score in 
percent which using a logarithm Table indicates the disease stage of the patient4,13. A 
total raw score of 30 is obtained, which is then converted into a logit score that ranges 
from 5.39 normal to -6.66 advanced/profound impairment. The score indicates six 
stages of severity: very mild, mild, moderate, severe, very severe and 
advanced/profound.  
The Brazilian version of FTD-FRS was generated after a translation and cross-
cultural adaptation processes which consisted of the following steps: translation, back-
translation (prepared by independent translators), evaluation of the back-translated 
version against the original version, discussion of the Portuguese version of the FTD-
FRS with specialists, development of a final version after minor adjustments, and pilot 
application in patients with a diagnosis of bvFTD and AD. This procedure has been 
described in detail in a previous study13. 
 
Procedures 
Data collection took place at the research centers involved in a room reserved for 
this purpose offering suitable lighting and acoustic conditions. Application of the 
protocol took around 60 minutes for patients and 45 minutes for healthy subjects. The 
interview with informants took around 45 minutes. The protocol was applied by 
previously trained examiners. 
 
Ethical aspects 
This study was approved by the Ethics Committee for Analysis of Research 
Projects (CAPPesq) of the Medical Board of the Clínicas Hospital and of the University 
of São Paulo School of Medicine, permit 311.601. All participants and their caregivers 
signed the Free and Informed Consent Form (TCLE) and were given explanations on 
the study procedures. The study was conducted in compliance with International ethics 
standards (Declaration of Helsinki). 
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Statistical analyses 
 
The Kolmogorov-Smirnov test confirmed that cognitive, functional and dementia 
staging variables did not have a normal distribution and non-parametric tests were 
therefore used for these variables. The Chi-square test was employed to compare the 
categorical variables among diagnostic groups. Kruskal-Wallis tests were used to make 
dementia subgroup comparisons in regards to age, years of education, and clinical 
variables such as ACE-R, MMSE, PFAQ and staging tools. Mann-Whitney tests were 
used for post hoc analyses.  When the Kruskal–Wallis test was significant, means were 
compared with the Bonferromi multiple comparisons test. Spearman’s correlations were 
used to analyze the relationship among the variables.  
The data from the 97 participants for the 30 items of the FTD-FRS were 
submitted to Exploratory Factor Analysis using the common factor model. This model 
holds that the variance observed in each measurement can be attributed to a relatively 
small number of common factors (i.e. common characteristics not observable in two or 
more variables) and to a single specific factor (not related with any other underlying 
factor from the model). Thus, the aim of exploratory factor analysis, with a common 
factor model, is to identify the common factors (separate from specific factors) and 
explain their relationship with the data observed. Varimax rotation was chosen in order 
to maximize the power of discrimination among the factors.  
Additionally, Cronbach´s α coefficient was calculated to analyze the internal 
consistency of the FTD-FRS and its domains. In a subsample of 22 healthy control 
subjects, temporal stability was tested by comparing FTD-FRS scores obtained in two 
applications (test and retest) with an interval of approximately two months (M=7.2 
weeks, SD=1.8), using two-way mixed intraclass correlation coefficient with absolute 
agreement. 
The data were keyed into Version 3.1 of the Epidata Program. All statistical 
analyses were performed using the SPSS v.17.0 and Statistica v.7.0 software packages. 
The level of significance adopted for the statistical tests was 5%, (i.e. a p-value<0.05). 
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Results 
Sociodemographic and clinical data of the studied sample 
 
A total of 97 individuals, comprising 31 diagnosed with bvFTD, 8 with PPA 
(semantic variant n=3 and non-fluent variant n=5), 28 with AD, and 8 with MCI, and a 
control group of 22 healthy subjects. Family members or caregivers who had frequent 
contact with the patient also took part. The patients with bvFTD and with AD had 
equivalent disease severity on the CDR-FTLD. The sociodemographic and clinical 
characteristics of the sample are given in Table 1. Patients with AD and PPA had worse 
performance on the MMSE and ACE-R relative to participants of the other groups. 
 
Insert Table 1 
 
Scores on the CDR-FTLD and FTD-FRS for the groups are given in Table 2. A 
significant difference was found among the groups on the CDR-FTLD and FTD-FRS, 
indicating greater severity in patients diagnosed with bvFTD.   
 
Insert Table 2 
 
Indicators of construct validity 
In order to achieve one of the objectives of the study, Bartlett´s test of Sphericity 
and the Kaiser-Meyer-Olkin (KMO) test were performed. The results indicated 
correlation among the items assessed on the FTD-FRS (χ2[df=435]= 2261.91; p<0.001) 
and sampling adequacy (KMO=0.715), respectively, for performing the exploratory 
factor analysis below. 
The exploratory factor analysis (with Varimax rotation) of the FTD-FRS 
revealed the existence of four factors, with eigenvalues >1, which together explained 
77.13% of the total variance with values from 1.28 to 17.52 (see Table 3). 
 
Insert Table 3 
 
The factor loadings matrix (i.e. the matrix whose values are the correlations 
among the original variables and common factors) for the four-factor solution is given 
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in Appendix A. The criteria for belonging to the factor was having a loading ≥ 0.5026-27. 
Factor 1 is associated with behavior, Factor 2 self-care and mobility, Factor 3 meal 
preparation, and Factor 4 to outings and shopping, household chores, finances and 
medications. 
The results of the analysis of the internal consistency of the factors found are 
given in Table 4. The overall instrument and each factor exhibited high consistency (> 
0.90) and the removal of items with lower factor loadings was not beneficial since it 
reduced the coefficients.  The analysis of temporal stability yielded a Kappa index of 
0.97 (p value< 0.001) suggesting high stability26,27. 
Insert Table 4 
 
Convergent validity of the FTD-FRS with the CDR-FTLD 
  
          Correlations of the factors of the FTD-FRS with the subdomains of the CDR-
FTLD scale are given in Table 5. The four proposed domains of the FTD-FRS showed 
significant correlations with the subdomains of the CDR-FTLD scale. 
 
Insert Table 5 
 
Discussion 
The objective of the present study was to examine the factor structure, internal 
consistency, temporal stability and convergent validity of the Brazilian version of the 
FTD-FRS. This is the first study that carried out an exploratory factorial analysis of the 
items composing the FTD-FRS. It is also the first to perform a convergent validation 
analysis with the CDR-FTLD and another scale specific for dementia staging for the 
DFT spectrum.  
 
Clinical findings 
Descriptive analyses suggested the CDR-FTLD appeared to underestimate the 
severity of dementia in bvFTD, as a substantial proportion of the patients rated as mild 
on the scale (CDR=1.0) had moderate or severe impairment according to the FTD-FRS. 
This finding supports recent evidence that the FTD-FRS may capture subtle changes 
associated with disease progression 4 that may not be observed when the original CDR 
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is used 4, 13 . However, in a more recent study 8, the CDR-FTLD, which includes 
language and behavior domains, was also shown to be sensitive for documenting 
decline in patients with FTD but a direct comparison between the FTD-FRS and the 
CDR-FTLD is yet to be conducted. 
In a previous imaging study 28, where the CDR-FTLD and FTD-FRS were 
correlated with brain perfusion in patients diagnosed with FTD, both scales were 
predictors of frontal lobe perfusion in the bvFTD patient group and predictors of 
temporal hypoperfusion in the PPA group. In the study, the authors considered the 
scales adequate for documenting severity in FTD. 
 
Psychometric characteristics of the FTD-FRS 
In the original FTD-FRS design and validation study4, the authors aimed to 
divide the questions by domains to facilitate their application in clinical practice. The 
scale in its original form contains 30 items organized into seven domains. The current 
exploratory factor analysis of the FTD-FRS identified the possibility to reduce the 
number of domains to four. In this new format, the first domain or Factor 1, with 6 
items (factor loadings of 0.67-0.81) is associated with behavior changes. The second 
domain or Factor 2, with 4 items (factor loadings of 0.81-0.85), is related to self-care 
and mobility. The third domain or Factor 3, comprising 8 items (factor loadings of 0.60-
0.87), is linked to meal preparation. Lastly, the fourth domain or Factor 4, comprising 
12 items (factor loadings of 0.50-0.81), relates to outings and shopping, household 
chores, finances and medications.  The high eigenvalues observed in the scale domains 
may reflect the behavioral changes of the sample which impact the basic and 
instrumental activities of daily living26-27, contemplated in FTD-FRS items4, 12,13.   
The four observed domains of the FTD-FRS correlated with the domains of the 
CDR-FTLD, consistent with a previous study12. These results indicate the convergent 
validity of the Brazilian version of the scale, according to the present exploratory factor 
analysis.  
The results for the internal consistency and reliability on the test-retest analyses 
suggested construct validity and temporal stability, congruent with the previous findings 
4, 12. The FTD-FRS is a recent scale and hence there are few studies investigating its 
psychometric characteristics. The present study is the first to document the factorial 
structure of the FTD-FRS and its convergent validity with the CDR-FTLD. These tools 
are key to determine dementia severity in FTD variants. 
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Determining disease severity in dementia, and especially in less prevalent sub-
types, is still a controversial issue. There is currently a lack of consensus regarding the 
definition of severity in dementia and its ideal staging tools29. Cognitive-based staging 
strategies are limited, since they are heavily dependent on language skills, which might 
overestimate disease severity, as observed in primary progressive aphasias30. 
Additionally, in developing countries, cutoff scores in cognitive tests are unsuitable for 
dementia staging because of great variability in educational background. The FTD-FRS 
may provide a better understanding of disease progression in FTD, by showing which 
abilities are lost early and late in the disease, as it relies on collateral information12. 
The present study has some limitations, including the fact that the sample 
studied was derived from a specialized outpatient clinic for cognitive disorders in adults 
and elderly and may possibly have contained a high proportion of individuals with 
specific needs or more severe symptoms. This might have introduced biases that could 
reduce the generalizability of results to other populations.  
In summary, the results suggest that the Brazilian FTD-FRS has satisfactory 
psychometric properties for clinical use. This instrument may aid in characterizing 
clinical symptoms relevant for diagnosis and disease staging. It may also document 
intervention-related outcomes. This study provides clinicians and researchers with a 
valid instrument with which to classify and follow up on patients diagnosed with FTD. 
The drafting of a severity scale adapted to the symptoms typical of FTD may facilitate 
early identification of these conditions and reduce delays between symptom onset and 
diagnosis. It would also aid in the selection and use of drug treatments, and 
implementing care. The FTD-FRS is a tool able to improve clinical attention to patients 
(and their family members), whether in the initial or terminal stages of FTD. 
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